sameridine: structure in first source
ID Source | ID |
---|---|
PubMed CID | 65996 |
CHEMBL ID | 2104504 |
SCHEMBL ID | 419071 |
MeSH ID | M0293755 |
Synonym |
---|
sameridine |
n-ethyl-1-hexyl-n-methyl-4-phenylpiperidine-4-carboxamide |
n-ethyl-1-hexyl-n-methyl-4-phenylisonipecotamide |
sameridine [inn] |
nqp2y50y6b , |
143257-97-0 |
unii-nqp2y50y6b |
AKOS015909863 |
CHEMBL2104504 |
SCHEMBL419071 |
DTXSID30162367 |
4-piperidinecarboxamide,n-ethyl-1-hexyl-n-methyl-4-phenyl- |
4-piperidinecarboxamide, n-ethyl-1-hexyl-n-methyl-4-phenyl- |
us9656961, example 00127 |
bdbm309407 |
n-ethyl-1-hexyl-n-methyl-4-phenyl-4-piperidinecarboxamide |
Q7409294 |
Sameridine is a new compound with both local anesthetic and opioid properties (partial micro -opioid receptor agonist) It is intended to be used intrathecally in order to provide both surgical anaesthesia and prolonged postoperative analgesia.
Excerpt | Reference | Relevance |
---|---|---|
"Sameridine has both local anesthetic and partial mu-opioid receptor agonistic properties. " | ( The effects on resting ventilation of intravenous infusions of morphine or sameridine, a novel molecule with both local anesthetic and opioid properties. Arlander, E; Eriksson, LI; Lindahl, SG; Osterlund, A, 1999) | 1.98 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 4 (44.44%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (55.56%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |